Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Hepatic chemoembolization: Effect of intraarterial lidocaine on pain and postprocedure recovery
Autore:
Hartnell, GG; Gates, J; Stuart, K; Underhill, J; Brophy, DP;
Indirizzi:
Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA Beth Israel Deaconess Med Ctr Boston MA USA 02215 l, Boston, MA 02215 USA
Titolo Testata:
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
fascicolo: 4, volume: 22, anno: 1999,
pagine: 293 - 297
SICI:
0174-1551(199907/08)22:4<293:HCEOIL>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
ARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; TUMORS; COMPLICATIONS; EMBOLIZATION; SURVIVAL;
Keywords:
anesthesia; chemotherapy, complications; embolism, therapeutic; hepatic arteries, therapeutic blockade; liver neoplasms, chemotherapeutic infusion;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
16
Recensione:
Indirizzi per estratti:
Indirizzo: Hartnell, GG Johns Hopkins Hosp, Dept Radiol, Blalock 545,600 N Wolfe St, Baltimore, MD21287 USA Johns Hopkins Hosp Blalock 545,600 N Wolfe St Baltimore MD USA 21287
Citazione:
G.G. Hartnell et al., "Hepatic chemoembolization: Effect of intraarterial lidocaine on pain and postprocedure recovery", CARDIO IN R, 22(4), 1999, pp. 293-297

Abstract

Purpose: To determine if intraarterial lidocaine reduces pain during and after chemoembolization, and whether it influences postprocedure recovery. Methods: Two patient cohorts undergoing selective hepatic chemoembolization were compared. Chemoembolization was performed without lidocaine (controlgroup) in 27 patients and intraarterial lidocaine was used (lidocaine group) in 29 similar patients. Objective changes in patient manage ment were assessed. Pain reduction in 31 more procedures with lidocaine (total 60) was assessed and related to tumor type. Results: During chemoembolization, intraarterial lidocaine reduced the need for additional intravenous analgesics from 69% to 19%. After chemoembolization the mean Dilaudid dose in the first 24 hr was reduced from 9.5 mg to 4.15 mg; accordingly, the mean length of hospital stay was reduced from 67.5 to 53.5 hr. During the day of chemoembolization, the mean oral fluid intake increased from 420 ml (control group) to 487 ml (lidocaine group); the percentage of patients taking solid food on the day of chemoembolization increased from 3% to 43%. Conclusion: Intraarterial lidocaine during chemoembolization reduces the severity and duration of pain after chemoembolization resulting in faster recovery thus reducing the length of hospitalization.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/07/20 alle ore 21:15:04